慢性肾脏病中尿钙排泄的决定因素与临床结局
结果显示eGFR与尿钙排泄正相关,尿钠、袢利尿剂、噻嗪类利尿剂、甲状旁腺激素和黑人种族与尿钙排泄独立相关,但尿钙排泄与不良结局的关联在调整基线eGFR后大幅减弱或消失。
要点
- CKD患者尿钙排泄显著低于一般人群,eGFR与24小时尿钙排泄正相关。
- 尿钠、袢利尿剂、噻嗪类利尿剂、PTH和黑人种族是尿钙排泄的独立决定因素。
- 尿钙排泄与不良结局的关联在调整基线eGFR后大幅减弱或消失。
核心结论
- CKD患者尿钙排泄明显低于一般人群,其决定因素因性别和CKD分期而异。
- 尿钙排泄与不良临床结局的关联在很大程度上被基线eGFR混杂。
主要发现
- eGFR与24小时尿钙排泄呈正相关。
- 男性中与24小时尿钙排泄最强的相关变量:24小时尿钠(β=0.19)、血清甲状旁腺激素(β=-0.22)、袢利尿剂(β=0.36)、噻嗪类利尿剂(β=-0.49)、自我认定的黑人种族(β=-0.23)。
- 女性中与24小时尿钙排泄最强的相关变量:24小时尿钠(β=0.28)、血清甲状旁腺激素(β=-0.20)、袢利尿剂(β=0.26)、噻嗪类利尿剂(β=-0.53)、自我认定的黑人种族(β=-0.27)。
- 较低的尿钙排泄与不良结局风险增加相关,但调整基线eGFR后这些关联大幅减弱或消失。
临床怎么用
- 在CKD患者中评估尿钙排泄时需考虑eGFR水平、利尿剂使用、PTH和种族等因素。
- 尿钙排泄与不良结局的关联可能主要由肾功能本身介导,不宜单独作为风险分层指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Abnormalities in calcium metabolism are common in chronic kidney disease (CKD). Diminished urinary calcium excretion may promote vascular calcification and increased urinary calcium excretion may lead to nephrolithiasis and nephrocalcinosis, conditions associated with CKD. OBJECTIVE: To study predictors of urinary calcium excretion and its association with adverse clinical outcomes in CKD. DESIGN, SETTING AND PATIENTS: This study assessed 3768 nondialysis participants in the Chronic Renal Insufficiency Cohort study from April 2003 to September 2008. Participants were followed up to October 2018. EXPOSURE: Clinically plausible predictors of urinary calcium excretion and 24-h urinary calcium excretion at baseline. MAIN OUTCOME MEASURES: Urinary calcium excretion; incident end stage kidney disease (ESKD), CKD progression [50% estimated glomerular filtration rate (eGFR) decline or incident ESKD], all-cause mortality, and atherosclerotic cardiovascular disease events. RESULTS: eGFR was positive correlated with 24-h urinary calcium excretion. The variables most strongly associated with 24-h urinary calcium excretion in males and females were 24-h urinary sodium (β = 0.19 and 0.28, respectively), serum parathyroid hormone (β = -0.22 and -0.20, respectively), loop diuretics (β = 0.36 and 0.26, respectively), thiazide diuretics (β = -0.49 and -0.53, respectively), and self-identified black race (β = -0.23 and -0.27, respectively). Lower urinary calcium excretion was associated with greater risks of adverse outcomes, but these associations were greatly attenuated or nullified after adjustment for baseline eGFR. CONCLUSION: Urinary calcium excretion is markedly lower in individuals with CKD compared to the general population. Determinants of urinary calcium excretion differed between sexes and levels of CKD. Associations between urinary calcium excretion and adverse clinical events were substantially confounded by eGFR.
引用
- Liu J, Tio MC, Verma A, et al. Determinants and Outcomes Associated With Urinary Calcium Excretion in Chronic Kidney Disease. J Clin Endocrinol Metab. 2022. PMID: 34390334. doi:10.1210/clinem/dgab574
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。